Stemtech (STEK) Common Equity (2020 - 2025)
Stemtech (STEK) has disclosed Common Equity for 6 consecutive years, with -$5.8 million as the latest value for Q3 2025.
- Quarterly Common Equity changed N/A to -$5.8 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$5.8 million through Sep 2025, changed N/A year-over-year, with the annual reading at -$4.5 million for FY2024, 61.37% down from the prior year.
- Common Equity hit -$5.8 million in Q3 2025 for Stemtech, up from -$6.5 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $896097.0 in Q1 2021 to a low of -$28.8 million in Q2 2022.
- Historically, Common Equity has averaged -$5.2 million across 5 years, with a median of -$4.5 million in 2024.
- Biggest five-year swings in Common Equity: crashed 11505.16% in 2022 and later surged 87.17% in 2023.
- Year by year, Common Equity stood at -$4.0 million in 2021, then grew by 20.81% to -$3.2 million in 2022, then grew by 12.39% to -$2.8 million in 2023, then plummeted by 61.37% to -$4.5 million in 2024, then dropped by 29.35% to -$5.8 million in 2025.
- Business Quant data shows Common Equity for STEK at -$5.8 million in Q3 2025, -$6.5 million in Q2 2025, and -$4.9 million in Q1 2025.